Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy with PBSC Support for Cisplatin-Resistant Germ Cell Tumors
NCT00003852Phase 2Terminated
- Sponsor
- Unicancer
- Start
- Mar 1998
- Primary completion
- Mar 2000
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of epirubicin, paclitaxel, cyclophosphamide, thiotepa, etoposide in germ cell tumor (GCT), sponsored by Unicancer. Started Mar 1998; status: terminated.
02
Drugs
epirubicinpaclitaxelcyclophosphamidethiotepaetoposide
03
Conditions
germ cell tumor (GCT)
Beyond the preview
Go deeper on NCT00003852.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003852.